BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DISC-3405 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DISC-3405\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07187973-10341@assetmemo.bio
DTSTAMP:20261121T005435Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:DISC-3405: Phase 1 readout est. (NCT07187973)
DESCRIPTION:DISC-3405\, phase 1\, Sickle Cell Disease.\nStudy: A Phase 1b\,
  Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (S
 CD)\nEstimated primary completion: June 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/disc-3405#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07187973
URL:https://assetmemo.bio/drug/disc-3405#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06985147-10341@assetmemo.bio
DTSTAMP:20261121T005435Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:DISC-3405: Phase 2 readout est. (NCT06985147)
DESCRIPTION:DISC-3405\, phase 2\, Polycythemia Vera.\nStudy: A Phase 2\, Op
 en-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)\nE
 stimated primary completion: July 2027. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/disc-3405#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT06985147
URL:https://assetmemo.bio/drug/disc-3405#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
